Market Size of north america pet nutraceuticals Industry
| Icons | Lable | Value |
|---|---|---|
|
Study Period | 2017 - 2029 |
|
Market Size (2024) | USD 2.27 Billion |
|
|
Market Size (2029) | USD 2.99 Billion |
|
Largest Share by Pets | Dogs |
|
|
CAGR (2024 - 2029) | 5.66 % |
|
Largest Share by Country | United States |
Major Players |
||
|
||
|
*Disclaimer: Major Players sorted in no particular order |
North America Pet Nutraceuticals Market Analysis
The North America Pet Nutraceuticals Market size is estimated at USD 2.27 billion in 2024, and is expected to reach USD 2.99 billion by 2029, growing at a CAGR of 5.66% during the forecast period (2024-2029).
2.27 Billion
Market Size in 2024 (USD)
2.99 Billion
Market Size in 2029 (USD)
2.42 %
CAGR (2017-2023)
5.66 %
CAGR (2024-2029)
Largest Market by Sub product
26.17 %
value share, Vitamins and Minerals, 2022
Rising pet health concerns have boosted the demand for vitamins and minerals in the region, as these supplements help promote metabolism and immunity in pets.
Largest Market by Country
88.71 %
value share, United States, 2022
Increasing pet ownership and growing interest among pet owners in natural and functional products, such as vitamins, minerals, and probiotics, have boosted the US market.
Fastest-growing Market by Sub Product
6.35 %
Projected CAGR, Vitamins and Minerals, 2023-2029
Rising pet populations and the ability of vitamins and minerals to regulate pet body functions and increase disease resistance will likely bolster their demand during the forecast period.
Fastest-growing Market by Country
9.42 %
Projected CAGR, Mexico, 2023-2029
Rising pet ownership rates, the growing trend of urbanization, and the increasing demand for high-quality and custom-made nutraceuticals have boosted the market in the country.
Leading Market Player
24.04 %
market share, Nestle (Purina), 2022
Nestle (Purina) is the market leader, as the company has focused on innovating new specific pet health products and expanding its manufacturing facilities in the region.
Dogs are the major consumers of nutraceuticals as they are susceptible to many health problems, such as joint problems and digestive issues
- Pet nutraceuticals are supplements that are specifically formulated to improve the health and well-being of pets. In 2022, they accounted for 2.8% of the North American pet food market. The share of nutraceuticals increased by 9.9% in 2022 compared to 2017, mainly due to the increasing awareness among pet owners about the importance of preventive healthcare. In 2021, a study revealed that four in 10 cat and dog owners in the United States had paid more attention to their pet's health since the start of the pandemic.
- Dogs accounted for the majority of the nutraceuticals market, valued at USD 1.24 billion, followed by cats and other pet animals at USD 581.4 million and USD 226 million, respectively. The larger share of dogs is mainly due to their larger population compared to other pets. In 2022, there were 144 million dogs in the region, while cats and other pet animals accounted for 96.5 million and 104.9 million, respectively. The United States has the largest pet population in the region, accounting for 69% (239 million). Additionally, dogs are known to suffer from a wider range of health issues, such as joint problems, skin allergies, and digestive issues, which has led to increased demand for nutraceuticals in the region. Joint/mobility, vitamin deficiency, general health, skin coat, and immunity are among the most popular conditions where pet owners are spending money on both dogs and cats.
- The growing trend of humanization among pet owners, the aging pet population, growing specialized needs, and the rise of e-commerce channels are the major factors driving the market, and it is projected to register a CAGR of 5.0% during the forecast period.
Understand The Key Trends Shaping This Market
Download Sample
The United States dominated the nutraceutical market, with vitamins and minerals as major nutraceuticals
- The North American pet nutraceuticals market has witnessed significant growth and is expected to continue this trend over the forecast period. One of the primary drivers of this growth is the increasing pet humanization trend, where pet owners are increasingly treating their pets as family members and focusing on their overall health and well-being.
- The United States dominated the market, and it accounted for 88.7% of the North American pet nutraceutical market value in 2022. The dominance of the United States is mainly due to its higher pet population in the country, with 239.1 million pets in 2022, which is about 69.2% of the North American pet population. With this huge pet population, the US pet nutraceuticals market value is anticipated to record a CAGR of 5.0% during the forecast period.
- Canada has the second-largest market share, accounting for USD 126.4 million in 2022. It has the second-largest share because of lower households adopting pets than the pets adopted in the United States. The country is expected to record a CAGR of 9.0% during the forecast period as there is an increase in awareness about pet health and growing pet expenditure. For instance, the pet population in Canada was 28.3 million in 2022.
- Mexico accounted for about 3.8% of the market share in 2022. The limited market share of the country is mainly due to the limited pet population in the country. However, with the rising trend in pet humanization, it is anticipated to register a CAGR of 9.4% during the forecast period.
- The pet nutraceuticals market in Rest of North America is anticipated to record a CAGR of 10.5% during the forecast period. The growing focus of pet owners on pet health and well-being is anticipated to boost the market during the forecast period.
